Similar articles

• The pharmacology of hypouricemic effect of benzbromarone.

  Sinclair DS, Fox IH. Sinclair DS, et al. J Rheumatol. 1975 Dec;2(4):437-45. J Rheumatol. 1975. PMID: 1206675
• Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.

  Moriwaki Y, Yamamoto T, Takahashi S, Hada T, Higashino K. Moriwaki Y, et al. Int J Clin Pharmacol Ther Toxicol. 1990 Feb;28(2):84-8. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2307550
• Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.

  Heel RC, Brogden RN, Speight TM, Avery GS. Heel RC, et al. Drugs. 1977 Nov;14(5):349-66. doi: 10.2165/00003495-197714050-00002. Drugs. 1977. PMID: 338280 Review.
• Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.

  Moriwaki Y, Yamamoto T, Takahashi S, Suda M, Agbedana OE, Hada T, Higashino K. Moriwaki Y, et al. Adv Exp Med Biol. 1991;309A:151-5. doi: 10.1007/978-1-4899-2638-8_34. Adv Exp Med Biol. 1991. PMID: 1789196 No abstract available.
• Pharmacologic approach to the maintenance of urate homeostasis.

  Kelley WN. Kelley WN. Nephron. 1975;14(1):99-115. doi: 10.1159/000180439. Nephron. 1975. PMID: 1091870 Review.